Company Analysis
Sign in

Sana Biotechnology, Inc. (SANA)

Nasdaq: SANA · Biological Products, (No Diagnostic Substances) · Seattle, WA · filing with the SEC since 2020
Full chart Alerts Compare
Grade5.0
◀ Past 6.2● Present 4.6▶ Future 4.5
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

6 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Sana Biotechnology, Inc.’s names, not what it holds today.

Patents granted
6
4 utility, 2 design, 1976 to Dec 31, 2025
Granted in 2025
1
Against 2 in 2024 and 2 in 2023
Applications published
52
22 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology4
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Sana Biotechnology, Inc. its own name
named as the applicant on its applications, in US
0 granted
32 published
Sana Biotechnology, Inc. its own name
US, as the owner printed on each patent
6 granted
20 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Feb 18, 2025D1,063,103Cryogenic vial storage rack assemblySana Biotechnology, Inc.
May 21, 202411,987,628Methods and compositions for modulating CAR-T activityBiotechnologySana Biotechnology, Inc.
Apr 23, 202411,965,022Methods and compositions for modulating CAR-T activityBiotechnologySana Biotechnology, Inc.
Oct 31, 202311,802,157Methods and compositions for modulating CAR-T activityBiotechnologySana Biotechnology, Inc.
Jul 4, 2023D991,484Cryogenic cassetteSana Biotechnology, Inc.
Dec 27, 202211,535,869CD8-specific antibody constructs and compositions thereofBiotechnologySana Biotechnology, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 30, 20252025/0333476ENGINEERED CD47 PROTEINS AND USES THEREOFBiotechnologySana Biotechnology, Inc.
Oct 30, 20252025/0333469USE OF CD8-TARGETED VIRAL VECTORSMedical technologySana Biotechnology, Inc.
Oct 16, 20252025/0320290METHODS FOR TRIGGERING SAFETY KILLING MECHANISMS USING A CD47-SIRPalpha BLOCKADE AGENTPharmaceuticalsSana Biotechnology, Inc.
Oct 9, 20252025/0313861METHODS OF ENGINEERING ALLOGENEIC T CELLS WITH A TRANSGENE IN A TCR LOCUS AND ASSOCIATED COMPOSITIONS AND METHODSBiotechnologySana Biotechnology, Inc.
Oct 2, 20252025/0302953METHODS OF TREATING PATIENTS EXHIBITING A PRIOR FAILED THERAPY WITH HYPOIMMUNOGENIC CELLSMedical technologySana Biotechnology, Inc.
Oct 2, 20252025/0302876CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR TREATING AUTOIMMUNE DISEASE AND ASSOCIATED METHODSBiotechnologySana Biotechnology, Inc.
Sep 11, 20252025/0281536CD4-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS AND USES THEREOFMedical technologySana Biotechnology, Inc.
Jul 17, 20252025/0230511METHODS AND REAGENTS FOR AMPLIFYING VIRAL VECTOR NUCLEIC ACID PRODUCTSBiotechnologySana Biotechnology, Inc.
Jul 17, 20252025/0230470SAFETY SWITCHES TO CONTROL IN VITRO AND IN VIVO PROLIFERATION OF CELL THERAPY PRODUCTSBiotechnologySana Biotechnology, Inc.
Jul 10, 20252025/0223564HYPOIMMUNE BETA CELLS DIFFERENTIATED FROM PLURIPOTENT STEM CELLS AND RELATED USES AND METHODSBiotechnologySana Biotechnology, Inc.
What it applied for, 2024 to 2025: Biotechnology 22 · Pharmaceuticals 5 · Medical technology 5 · Basic materials chemistry 1 · Chemical engineering 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton SANA · research, not advice